Shire

CAMBRIDGE, Massachusetts and BASINGSTOKE, England, February 28, 2011 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its support of World Rare Disease Day, joining patients, physicians, and patient organizations around the world to support a day that focuses attention on rare diseases as a public health issue and highlights the need for more understanding and awareness about these diseases.